Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
29.65
-0.34 (-1.13%)
Nov 21, 2024, 11:09 AM EST - Market open
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $3.05 billion as of November 21, 2024. Its market cap has increased by 430.85% in one year.
Market Cap
3.05B
Enterprise Value
2.35B
1-Year Change
430.85%
Ranking
Category
Stock Price
$29.94
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $3.05B, an increase of 285.18%. That is a compound annual growth rate of 38.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 3.05B | 273.88% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verona Pharma | 3.12B |
| MoonLake Immunotherapeutics | 3.11B |
| Agios Pharmaceuticals | 3.10B |
| PTC Therapeutics | 3.04B |
| Veracyte | 3.03B |
| Bausch Health Companies | 3.01B |
| Inari Medical | 2.98B |
| Edgewise Therapeutics | 2.98B |